LAMP2 and Alzheimer disease: Our finding that LAMP2 is overexpressed in fibroblasts from AD patients, may be due to the fact that the group of patients for this study are in the early stages of AD pathology and are still asymptomatic, but the pathological changes/environment could be starting and contributing to the overexpression of LAMP-2A as a compensatory mechanism.